Showing results (371-380 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|June 9, 2016
The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patientsRoberto W Dal Negro, Massimiliano PoveroClinicoeconomics and Outcomes Research : CEOR|June 9, 2016
Prolonged length of stay associated with air leak following pulmonary resection has a negative impact on hospital marginDouglas E Wood, Lisa M Lauer, Andrew Layton, et al.Clinicoeconomics and Outcomes Research : CEOR|November 11, 2017
Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in FranceMaud Pignata, Christos Chouaid, Katell Le Lay, et al.Clinicoeconomics and Outcomes Research : CEOR|December 5, 2017
Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?Nigel Sb Rawson, John AdamsClinicoeconomics and Outcomes Research : CEOR|November 30, 2017
Propofol or benzodiazepines for short- and long-term sedation in intensive care units? An economic evaluation based on meta-analytic resultsLorenzo Pradelli, Massimiliano Povero, Hartmut Bürkle, et al.Clinicoeconomics and Outcomes Research : CEOR|October 17, 2017
Drug tendering: drug supply and shortage implications for the uptake of biosimilarsGeorge Dranitsaris, Ira Jacobs, Carol Kirchhoff, et al.Clinicoeconomics and Outcomes Research : CEOR|September 2, 2017
Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitalsJesse D Ortendahl, Sonia J Pulgar, Beloo Mirakhur, et al.Clinicoeconomics and Outcomes Research : CEOR|June 30, 2016
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UKOskar Eklund, Faraz Afzal, Fredrik Borgström, et al.Clinicoeconomics and Outcomes Research : CEOR|July 2, 2016
Savings associated with high-dose hypoallergenic house dust mite immunotherapy in rhinitis and/or asthma patients in SpainJosé Carlos García Robaina, Carlos Polanco Sánchez, Elvira Estella PérezClinicoeconomics and Outcomes Research : CEOR|November 18, 2020
A Model to Predict Risk of Hyperkalemia in Patients with Chronic Kidney Disease Using a Large Administrative Claims DatabaseAjay Sharma, Paula J Alvarez, Steven D Woods, et al.Pageof 102